LCM
GSK icon

Liberty Capital Management’s GSK GSK Stock Holding History

Liberty Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-156
Closed -$8K – 277
2017
Q2 		$8K Hold
156
– – ﹤0.01% 240
2017
Q1 		$8K Hold
156
– – ﹤0.01% 234
2016
Q4 		$8K Hold
156
– – 0.01% 226
2016
Q3 		$8K Buy
+156
New +$8.55K 0.01% 221

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Liberty Capital Management's GSK Position: Q3 2017 in Review

Liberty Capital Management sold out of GSK (GSK) in Q3 2017, closing a stake of 156 shares — an estimated $8K sold.

Liberty Capital Management first reported a position in GSK in Q3 2016 and held it in 4 quarters. The position peaked at $8K in Q2 2017. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Liberty Capital Management reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Liberty Capital Management sold 156 GSK shares in Q3 2017, an estimated $8K.
  • Liberty Capital Management first reported a position in GSK in Q3 2016 and held it in 4 quarters.
  • Liberty Capital Management's GSK position peaked at $8K in Q2 2017.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Liberty Capital Management's 13F filing for Q3 2017, filed 25 Oct 2017.